Related Experiment Video
Updated: May 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Pathophysiological aspects of the diabetogenic effect of statins]
Sascha Pilemann-Lyberg1, Anette Bratt Solis, Peter Gæde
1Klintemarken 15, 2860 Søborg. pilemannlyberg@gmail.com.
Abstract:
Statins are potent inhibitors of cholesterol biosynthesis. Statins are beneficial in the primary and secondary prevention of coronary heart disease. Recent studies indicate that there is an association between statin use and the development of new-onset diabetes mellitus. This article reviews the patophysiological mechanisms by different statins to explain this association.
Insights
Statins effectively prevent heart disease but may increase the risk of developing new-onset diabetes mellitus. This review explores the mechanisms behind this association.
Area of Science:
- Pharmacology
- Endocrinology
- Cardiology
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Diabetic Ketoacidosis ll: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetic Neuropathy

